Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.23.2
Note 8 - Accrued Liabilities
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.         Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

   

June 30, 2023

   

December 31, 2022

 

Accrued compensation

  $ 476     $ 667  

Accrued research and other professional fees

    365       215  

Accrued clinical trial costs

    164       472  

Accrued other liabilities

    6       11  

Total accrued liabilities

  $ 1,011     $ 1,365